ID   LX15B_RAT               Reviewed;         677 AA.
AC   Q8K4F2;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   08-NOV-2023, entry version 121.
DE   RecName: Full=Polyunsaturated fatty acid lipoxygenase ALOX15B {ECO:0000305};
DE   AltName: Full=15-lipoxygenase 2 {ECO:0000250|UniProtKB:O15296};
DE            Short=15-LOX-2 {ECO:0000250|UniProtKB:O15296};
DE   AltName: Full=Arachidonate 15-lipoxygenase B;
DE            Short=15-LOX-B;
DE            EC=1.13.11.33 {ECO:0000269|PubMed:23382512};
DE   AltName: Full=Arachidonate 15-lipoxygenase type II;
DE   AltName: Full=Linoleate 13-lipoxygenase 15-LOb;
DE            EC=1.13.11.- {ECO:0000269|PubMed:23382512};
GN   Name=Alox15b {ECO:0000312|RGD:628809};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Boeglin W.E., Schneider C., Brash A.R.;
RT   "A 15-lipoxygenase in the rat, homolog of human 15-lipoxygenase-2 and mouse
RT   8-lipoxygenase.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=23382512; DOI=10.1096/fj.12-217414;
RA   Gregus A.M., Dumlao D.S., Wei S.C., Norris P.C., Catella L.C.,
RA   Meyerstein F.G., Buczynski M.W., Steinauer J.J., Fitzsimmons B.L.,
RA   Yaksh T.L., Dennis E.A.;
RT   "Systematic analysis of rat 12/15-lipoxygenase enzymes reveals critical
RT   role for spinal eLOX3 hepoxilin synthase activity in inflammatory
RT   hyperalgesia.";
RL   FASEB J. 27:1939-1949(2013).
CC   -!- FUNCTION: Non-heme iron-containing dioxygenase that catalyzes the
CC       stereo-specific peroxidation of free and esterified polyunsaturated
CC       fatty acids (PUFAs) generating a spectrum of bioactive lipid mediators
CC       (PubMed:23382512). Inserts a peroxyl group at C15 of arachidonate
CC       ((5Z,8Z,11Z,14Z)-eicosatetraenoate) producing (15S)-
CC       hydroperoxyeicosatetraenoate/(15S)-HPETE (PubMed:23382512). Also
CC       peroxidizes linoleate ((9Z,12Z)-octadecadienoate) to 13-
CC       hydroperoxyoctadecadienoate/13-HPODE (PubMed:23382512). Oxygenates
CC       arachidonyl derivatives such as 2-arachidonoylglycerol (2-AG) leading
CC       to the production and extracellular release of 15-
CC       hydroxyeicosatetraenoyl glycerol (15-HETE-G) that acts as a peroxisome
CC       proliferator-activated receptor alpha agonist.Has the ability to
CC       efficiently class-switch ALOX5 pro-inflammatory mediators into anti-
CC       inflammatory intermediates. Participates in the sequential oxidations
CC       of DHA ((4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate) to generate
CC       specialized pro-resolving mediators (SPMs) resolvin D5 ((7S,17S)-
CC       diHPDHA), which can actively down-regulate the immune response and have
CC       anti-aggregation properties with platelets. In addition to free PUFAs
CC       hydrolyzed from phospholipids, it directly oxidizes PUFAs esterified to
CC       membrane-bound phospholipids. Has no detectable 8S-lipoxygenase
CC       activity on arachidonate but reacts with (8S)-HPETE to produce
CC       (8S,15S)-diHPETE. May regulate progression through the cell cycle and
CC       cell proliferation. May also regulate cytokine secretion by macrophages
CC       and therefore play a role in the immune response. May also regulate
CC       macrophage differentiation into proatherogenic foam cells (By
CC       similarity). {ECO:0000250|UniProtKB:O15296,
CC       ECO:0000269|PubMed:23382512}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = (15S)-hydroperoxy-
CC         (5Z,8Z,11Z,13E)-eicosatetraenoate; Xref=Rhea:RHEA:16869,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:32395, ChEBI:CHEBI:57446;
CC         EC=1.13.11.33; Evidence={ECO:0000269|PubMed:23382512};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16870;
CC         Evidence={ECO:0000305|PubMed:23382512};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoate + O2 = 13-hydroperoxy-(9Z,11E)-
CC         octadecadienoate; Xref=Rhea:RHEA:48848, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:30245, ChEBI:CHEBI:90823;
CC         Evidence={ECO:0000269|PubMed:23382512};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48849;
CC         Evidence={ECO:0000305|PubMed:23382512};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5S)-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + O2 = (5S)-
CC         hydroxy-(15S)-hydroperoxy-(6E,8Z,11Z,13E)-eicosatetraenoate;
CC         Xref=Rhea:RHEA:53660, ChEBI:CHEBI:15379, ChEBI:CHEBI:90632,
CC         ChEBI:CHEBI:137546; Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53661;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = 5-hydroperoxy-
CC         (6E,8Z,11Z,14Z)-eicosatetraenoate; Xref=Rhea:RHEA:48844,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:32395, ChEBI:CHEBI:90822;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48845;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5S,6R)-dihydroxy-(7E,9E,11Z,14Z)-eicosatetraenoate + O2 =
CC         (5S,6R)-dihydroxy-(15S)-hydroperoxy-(7E,9E,11Z,13E)-
CC         eicosatetraenoate; Xref=Rhea:RHEA:53656, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:137542, ChEBI:CHEBI:137547;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53657;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + O2 =
CC         (5S,15S)-dihydroperoxy-(6E,8Z,11Z,13E)-eicosatetraenoate;
CC         Xref=Rhea:RHEA:53652, ChEBI:CHEBI:15379, ChEBI:CHEBI:57450,
CC         ChEBI:CHEBI:137543; Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53653;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + O2 = 2-[15(S)-
CC         hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl]-glycerol;
CC         Xref=Rhea:RHEA:53332, ChEBI:CHEBI:15379, ChEBI:CHEBI:52392,
CC         ChEBI:CHEBI:137187; Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53333;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(8S)-hydroperoxy-(5Z,9E,11Z,14Z)-eicosatetraenoate + O2 =
CC         (8S,15S)-dihydroperoxy-(5Z,9E,11Z,13E)-eicosatetraenoate;
CC         Xref=Rhea:RHEA:50932, ChEBI:CHEBI:15379, ChEBI:CHEBI:75322,
CC         ChEBI:CHEBI:133899; Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50933;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-alanine + O2 = N-(15S)-
CC         hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl-alanine;
CC         Xref=Rhea:RHEA:50184, ChEBI:CHEBI:15379, ChEBI:CHEBI:132071,
CC         ChEBI:CHEBI:132077; Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50185;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-gamma-aminobutanoate + O2 =
CC         N-(15S)-hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl-gamma-
CC         aminobutanoate; Xref=Rhea:RHEA:50180, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:132072, ChEBI:CHEBI:132078;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50181;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-glycine + O2 = N-(15S)-
CC         hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl-glycine;
CC         Xref=Rhea:RHEA:50188, ChEBI:CHEBI:15379, ChEBI:CHEBI:59002,
CC         ChEBI:CHEBI:132076; Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50189;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-taurine + O2 = N-(15S)-
CC         hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl-taurine;
CC         Xref=Rhea:RHEA:50156, ChEBI:CHEBI:15379, ChEBI:CHEBI:132060,
CC         ChEBI:CHEBI:132062; Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50157;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + O2 = 2-[12-
CC         hydroperoxy-(5Z,8Z,10E,14Z)-eicosatetraenoyl]-glycerol;
CC         Xref=Rhea:RHEA:63224, ChEBI:CHEBI:15379, ChEBI:CHEBI:52392,
CC         ChEBI:CHEBI:146254; Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63225;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphocholine + O2 = 1-octadecanoyl-2-(15-hydroperoxy-
CC         5Z,8Z,11Z,13E-eicosatetraenoyl)-sn-glycero-3-phosphocholine;
CC         Xref=Rhea:RHEA:63264, ChEBI:CHEBI:15379, ChEBI:CHEBI:74965,
CC         ChEBI:CHEBI:146283; Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63265;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-
CC         phospho-(1D-myo-inositol) + O2 = a 1-acyl-2-(15-hydroperoxy-
CC         5Z,8Z,11Z,13E-eicosatetraenoyl)-sn-glycero-3-phospho-(1D-myo-
CC         inositol); Xref=Rhea:RHEA:63276, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:75243, ChEBI:CHEBI:146285;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63277;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phospho-
CC         (1D-myo-inositol) + O2 = a 1-acyl-2-(15-hydroperoxy-8Z,11Z,13E-
CC         eicosatrienoyl)-sn-glycero-3-phospho-(1D-myo-inositol);
CC         Xref=Rhea:RHEA:63280, ChEBI:CHEBI:15379, ChEBI:CHEBI:146286,
CC         ChEBI:CHEBI:146287; Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63281;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-
CC         3-phosphoethanolamine + O2 = 1-octadecanoyl-2-(15-hydroperoxy-
CC         5Z,8Z,11Z,13E-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine;
CC         Xref=Rhea:RHEA:63268, ChEBI:CHEBI:15379, ChEBI:CHEBI:78268,
CC         ChEBI:CHEBI:146282; Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63269;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phospho-(1D-myo-inositol) + O2 = 1-octadecanoyl-2-(15-hydroperoxy-
CC         5Z,8Z,11Z,13E-eicosatetraenoyl)-sn-glycero-3-phospho-(1D-myo-
CC         inositol); Xref=Rhea:RHEA:63272, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:133606, ChEBI:CHEBI:146284;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63273;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(8Z,11Z,14Z)-eicosatrienoate + O2 = 15-hydroperoxy-
CC         (8Z,11Z,13E)-eicosatrienoate; Xref=Rhea:RHEA:63312,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:71589, ChEBI:CHEBI:146292;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63313;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(7S)-hydroperoxy-(4Z,8E,10Z,13Z,16Z,19Z)-docosahexaenoate + O2
CC         = (7S,17S)-dihydroperoxy-(4Z,8E,10Z,13Z,15E,19Z)-docosahexaenoate;
CC         Xref=Rhea:RHEA:64728, ChEBI:CHEBI:15379, ChEBI:CHEBI:140349,
CC         ChEBI:CHEBI:156049; Evidence={ECO:0000250|UniProtKB:O15296};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64729;
CC         Evidence={ECO:0000250|UniProtKB:O15296};
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC         Evidence={ECO:0000250|UniProtKB:O15296,
CC         ECO:0000255|PROSITE-ProRule:PRU00726};
CC       Note=Binds 1 Fe cation per subunit. {ECO:0000250|UniProtKB:O15296,
CC       ECO:0000255|PROSITE-ProRule:PRU00726};
CC   -!- PATHWAY: Lipid metabolism; hydroperoxy eicosatetraenoic acid
CC       biosynthesis. {ECO:0000269|PubMed:23382512}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:O15296}. Cell membrane
CC       {ECO:0000250|UniProtKB:O15296}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:O15296}. Membrane
CC       {ECO:0000250|UniProtKB:O15296}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:O15296}. Cell junction, adherens junction
CC       {ECO:0000250|UniProtKB:O15296}. Cell junction, focal adhesion
CC       {ECO:0000250|UniProtKB:O15296}. Nucleus {ECO:0000250|UniProtKB:O15296}.
CC       Note=Predominantly cytosolic; becomes enriched at membranes upon
CC       calcium binding. {ECO:0000250|UniProtKB:O15296}.
CC   -!- DOMAIN: The PLAT domain can bind calcium ions; this promotes
CC       association with membranes. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the lipoxygenase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF415240; AAN03708.1; -; mRNA.
DR   RefSeq; NP_695213.1; NM_153301.2.
DR   AlphaFoldDB; Q8K4F2; -.
DR   SMR; Q8K4F2; -.
DR   STRING; 10116.ENSRNOP00000010416; -.
DR   BindingDB; Q8K4F2; -.
DR   ChEMBL; CHEMBL3289; -.
DR   PhosphoSitePlus; Q8K4F2; -.
DR   PaxDb; 10116-ENSRNOP00000010416; -.
DR   GeneID; 266604; -.
DR   KEGG; rno:266604; -.
DR   UCSC; RGD:628809; rat.
DR   AGR; RGD:628809; -.
DR   CTD; 247; -.
DR   RGD; 628809; Alox15b.
DR   eggNOG; ENOG502QVKD; Eukaryota.
DR   InParanoid; Q8K4F2; -.
DR   OrthoDB; 999249at2759; -.
DR   PhylomeDB; Q8K4F2; -.
DR   BRENDA; 1.13.11.33; 5301.
DR   Reactome; R-RNO-2142770; Synthesis of 15-eicosatetraenoic acid derivatives.
DR   UniPathway; UPA00881; -.
DR   PRO; PR:Q8K4F2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005912; C:adherens junction; ISS:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0050473; F:arachidonate 15-lipoxygenase activity; IDA:UniProtKB.
DR   GO; GO:0036403; F:arachidonate 8(S)-lipoxygenase activity; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; ISS:UniProtKB.
DR   GO; GO:0016165; F:linoleate 13S-lipoxygenase activity; ISO:RGD.
DR   GO; GO:1990136; F:linoleate 9S-lipoxygenase activity; ISO:RGD.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB.
DR   GO; GO:1901696; P:cannabinoid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0071926; P:endocannabinoid signaling pathway; ISS:UniProtKB.
DR   GO; GO:0051122; P:hepoxilin biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0043651; P:linoleic acid metabolic process; ISO:RGD.
DR   GO; GO:0006629; P:lipid metabolic process; ISO:RGD.
DR   GO; GO:0034440; P:lipid oxidation; IBA:GO_Central.
DR   GO; GO:2001303; P:lipoxin A4 biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0019372; P:lipoxygenase pathway; IDA:UniProtKB.
DR   GO; GO:0045786; P:negative regulation of cell cycle; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0045926; P:negative regulation of growth; ISO:RGD.
DR   GO; GO:0006644; P:phospholipid metabolic process; ISS:UniProtKB.
DR   GO; GO:0032722; P:positive regulation of chemokine production; ISO:RGD.
DR   GO; GO:0045618; P:positive regulation of keratinocyte differentiation; ISO:RGD.
DR   GO; GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; ISO:RGD.
DR   GO; GO:0035360; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; ISO:RGD.
DR   CDD; cd01753; PLAT_LOX; 1.
DR   Gene3D; 3.10.450.60; -; 1.
DR   Gene3D; 2.60.60.20; PLAT/LH2 domain; 1.
DR   InterPro; IPR000907; LipOase.
DR   InterPro; IPR013819; LipOase_C.
DR   InterPro; IPR036226; LipOase_C_sf.
DR   InterPro; IPR020834; LipOase_CS.
DR   InterPro; IPR020833; LipOase_Fe_BS.
DR   InterPro; IPR001885; LipOase_mml.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   InterPro; IPR036392; PLAT/LH2_dom_sf.
DR   InterPro; IPR042062; PLAT_LOX_verte.
DR   PANTHER; PTHR11771; LIPOXYGENASE; 1.
DR   PANTHER; PTHR11771:SF161; POLYUNSATURATED FATTY ACID LIPOXYGENASE ALOX15B; 1.
DR   Pfam; PF00305; Lipoxygenase; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   PRINTS; PR00087; LIPOXYGENASE.
DR   PRINTS; PR00467; MAMLPOXGNASE.
DR   SMART; SM00308; LH2; 1.
DR   SUPFAM; SSF49723; Lipase/lipooxygenase domain (PLAT/LH2 domain); 1.
DR   SUPFAM; SSF48484; Lipoxigenase; 1.
DR   PROSITE; PS00711; LIPOXYGENASE_1; 1.
DR   PROSITE; PS00081; LIPOXYGENASE_2; 1.
DR   PROSITE; PS51393; LIPOXYGENASE_3; 1.
DR   PROSITE; PS50095; PLAT; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell junction; Cell membrane; Cytoplasm; Cytoskeleton;
KW   Dioxygenase; Iron; Lipid metabolism; Lipid-binding; Membrane;
KW   Metal-binding; Nucleus; Oxidoreductase; Reference proteome.
FT   CHAIN           1..677
FT                   /note="Polyunsaturated fatty acid lipoxygenase ALOX15B"
FT                   /id="PRO_0000220702"
FT   DOMAIN          2..125
FT                   /note="PLAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00152"
FT   DOMAIN          126..677
FT                   /note="Lipoxygenase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         15
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:O15296"
FT   BINDING         17
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:O15296"
FT   BINDING         39
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O15296"
FT   BINDING         40
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O15296"
FT   BINDING         42
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O15296"
FT   BINDING         44
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O15296"
FT   BINDING         86
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:O15296"
FT   BINDING         87
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:O15296"
FT   BINDING         374
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         379
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         554
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         677
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
SQ   SEQUENCE   677 AA;  76145 MW;  49A47B47C491B8B1 CRC64;
     MAKFRVRVST GEACGAGTWD KVSVSIVGTH GESPLVPLDH LGKEFSAGAE EDFEVTLPQD
     VGTVLMLRIH KAPPEAPLPL LSFPPDAWYC RWFELEWLPG AALRFPCYQW LEGAGELVLR
     EGAAKVSWQD HHRTLQDQRQ KELESRKDMY SWKTYIEGWP HCLDHETVKD LDLNIKYSAM
     KNAKFFFKAQ SAFTELKFKG LLDRTGLWRS LREMKRMFNF HNTPAAEYVF AHWQEDAFFA
     SQFLNGLNPV LIRRCRRLPE NFPVTDEMVA PVLGPGTSLQ AELEKGSLFL VDHGILSGVQ
     TNVINGKPQF SAAPMTLLYQ SPGSGPLLPI AIQLKQTPGP DNPIFLPSDD KWDWLLAKTW
     VRNAEFSIHE ALTHLLHAHL IPEVFALATL RQLPHCHPLF KLLIPHTRYT LHINTLAREL
     LIAPGKVVDK STGLGIGGFS DLIKRNMEQL SYSVLCLPED IRARDVGDLP GYYYRDDGMQ
     IWSAIRSFVS EIVDIYYPSD ASVRDDQELQ AWVGEIFSEG FLSQESSGMP SLLDTQEALV
     QYVTMVIFTC SAKHAAVSAS QFDSCVWMPN LPPSMQLPPP TSKGQASPEG FIATLPAVNA
     TCDVIIALWL LSKEPGDRRP LGHYPDEHFT EEVPRRSIAA FQRKLIQISS GIRKRNQSLA
     LPYTYLDPPL IENSVSI
//
